These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. G-protein-coupled receptor-focused drug discovery using a target class platform approach. Heilker R, Wolff M, Tautermann CS, Bieler M. Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411 [Abstract] [Full Text] [Related]
24. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data. Stott LA, Hall DA, Holliday ND. Biochem Pharmacol; 2016 Feb 01; 101():1-12. PubMed ID: 26478533 [Abstract] [Full Text] [Related]
34. Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor. Galandrin S, Oligny-Longpré G, Bonin H, Ogawa K, Galés C, Bouvier M. Mol Pharmacol; 2008 Jul 01; 74(1):162-72. PubMed ID: 18403719 [Abstract] [Full Text] [Related]
35. G protein coupled receptors as allosteric proteins and the role of allosteric modulators. Kenakin T. J Recept Signal Transduct Res; 2010 Oct 01; 30(5):313-21. PubMed ID: 20858023 [Abstract] [Full Text] [Related]
37. Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy. van der Westhuizen ET, Breton B, Christopoulos A, Bouvier M. Mol Pharmacol; 2014 Mar 01; 85(3):492-509. PubMed ID: 24366668 [Abstract] [Full Text] [Related]